Key facts
- Siftwell’s last known valuation is $17.6M (Nov 2025).
- It has raised $9.3M; the latest was Seed Round ($3.5M) in Nov 2025.
- Notable investors include Gaingels, Endless Frontier Labs, AlleyCorp, Tau Ventures, Arkin Capital — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Siftwell
- ·The full record, as it builds
Funding rounds
No funding rounds for Siftwell are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Siftwell
Developer of a machine learning-based analytics platform designed to optimize healthcare operations and clinical workflows. The company offers integrated analysis of structured and unstructured clinical data with predictive modeling, natural language processing, customizable dashboards, and automated reporting, enabling healthcare providers to streamline workflows, reduce costs, and enhance patient outcomes.
- Sector
- Healthcare
- HQ
- Charlotte, NC, United States
- Founded
- 2021
- Employees
- 15
- Website
- siftwell.ai/
- Ownership
- Privately Held (backing)
Siftwell doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Siftwell shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Siftwell in its N-PORT filings yet. We sweep new filings monthly.